| Drug Name: | Chlorotrianisene (569-57-3) |
|---|---|
| PubChem ID: | 11289 |
| SMILES: | COC1=CC=C(C=C1)C(=C(C2=CC=C(C=C2)OC)Cl)C3=CC=C(C=C3)OC |
| InchiKey: | BFPSDSIWYFKGBC-UHFFFAOYSA-N |
| Therapeutic Category: | Antineoplastic Agents, Estrogens, Hormones |
| Molecular Weight (dalton) | : | 380.871 |
| LogP | : | 5.8678 |
| Ring Count | : | 3 |
| Hydrogen Bond Acceptor Count | : | 3 |
| Hydrogen Bond Donor Count | : | 0 |
| Total Polar Surface Area | : | 27.69 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|---|---|---|
| Abdominal Pain | Histamine H1 receptor (P35367) | Not Available | Large-scale prediction and testing of drug activity on side-effect targets |
| Cerebral-Vein Thrombosis | factor V (P12259) | Increased risk of deep-vein and cerebral-vein thrombosis with oral contraceptives [ ADR Type 2 ] | Venous thrombosis--the interaction of genes and environment |
| Cerebral-Vein Thrombosis | Prothrombin (P00734) | Increased risk of deep-vein and cerebral-vein thrombosis with oral contraceptives. [ ADR Type 2 ] | Venous thrombosis--the interaction of genes and environment |
| Deep Vein Thrombosis | Prothrombin (P00734) | Increased risk of deep-vein and cerebral-vein thrombosis with oral contraceptives. [ ADR Type 2 ] | Venous thrombosis--the interaction of genes and environment |
| Rash | Histamine H1 receptor (P35367) | Not Available | Large-scale prediction and testing of drug activity on side-effect targets |
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category